Anterix Inc.
NASDAQ:ATEX
38.87 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4.191 | 1.919 | 1.084 | 0.921 | 1.564 | 6.499 | 6.355 | 4.787 | 3.544 | 3.172 | 3.54 | 2.76 |
| Cost of Revenue
| 0.848 | 0.005 | 0.005 | 1.606 | 2.833 | 7.251 | 7.898 | 7.049 | 3.469 | 1.063 | 1.124 | 0.826 |
| Gross Profit
| 3.343 | 1.914 | 1.079 | -0.685 | -1.269 | -0.752 | -1.543 | -2.262 | 0.075 | 2.108 | 2.415 | 1.934 |
| Gross Profit Ratio
| 0.798 | 0.997 | 0.995 | -0.744 | -0.811 | -0.116 | -0.243 | -0.473 | 0.021 | 0.665 | 0.682 | 0.701 |
| Reseach & Development Expenses
| 5.697 | 4.439 | 3.593 | 4.343 | 2.693 | 2.311 | 2.352 | 2.316 | 1.323 | 1.001 | 0.935 | 0.716 |
| General & Administrative Expenses
| 44.423 | 45.177 | 39.525 | 39.237 | 25.702 | 25.62 | 20.864 | 22.553 | 16.726 | 13.362 | 0.926 | 0.933 |
| Selling & Marketing Expenses
| 5.693 | 5.733 | 4.461 | 2.942 | 3.846 | 3.679 | 6.967 | 5.652 | 3.956 | 1.813 | 1.382 | 1.248 |
| SG&A
| 50.112 | 50.91 | 43.986 | 42.179 | 29.548 | 29.299 | 27.831 | 28.205 | 20.682 | 15.175 | 2.308 | 2.181 |
| Other Expenses
| 0.233 | 1.42 | 1.45 | 3.533 | 3.591 | -0.028 | -0.078 | -0.028 | 0.001 | 0.096 | 0.059 | 0.053 |
| Operating Expenses
| 55.809 | 56.769 | 49.029 | 50.055 | 35.832 | 31.61 | 30.183 | 30.521 | 22.004 | 16.272 | 3.302 | 2.949 |
| Operating Income
| -52.466 | -54.85 | -47.95 | -54.809 | -37.383 | -42.742 | -31.726 | -32.783 | -21.93 | -14.163 | -0.886 | -1.015 |
| Operating Income Ratio
| -12.519 | -28.583 | -44.234 | -59.51 | -23.902 | -6.577 | -4.992 | -6.848 | -6.189 | -4.466 | -0.25 | -0.368 |
| Total Other Income Expenses Net
| 44.951 | 39.795 | 11.414 | 0.499 | 2.147 | -10.408 | -0.078 | -0.028 | 0.001 | -0.551 | -0.325 | -0.225 |
| Income Before Tax
| -7.515 | -15.055 | -36.536 | -54.31 | -35.236 | -41.308 | -31.066 | -32.688 | -21.828 | -14.714 | -1.212 | -1.24 |
| Income Before Tax Ratio
| -1.793 | -7.845 | -33.705 | -58.969 | -22.529 | -6.356 | -4.888 | -6.828 | -6.16 | -4.639 | -0.342 | -0.449 |
| Income Tax Expense
| 1.613 | 1.262 | 0.983 | 0.124 | 2.402 | 0.685 | -0.438 | 6.498 | 0.004 | 0.02 | 0 | 0 |
| Net Income
| -9.128 | -16.317 | -37.519 | -54.434 | -37.638 | -41.993 | -30.628 | -39.186 | -21.828 | -14.714 | -1.212 | -1.24 |
| Net Income Ratio
| -2.178 | -8.503 | -34.612 | -59.103 | -24.065 | -6.461 | -4.82 | -8.186 | -6.16 | -4.639 | -0.342 | -0.449 |
| EPS
| -0.49 | -0.87 | -2.07 | -3.13 | -2.29 | -2.88 | -2.12 | -2.72 | -1.54 | -1.46 | -0.13 | -0.14 |
| EPS Diluted
| -0.49 | -0.87 | -2.07 | -3.13 | -2.29 | -2.88 | -2.12 | -2.72 | -1.54 | -1.46 | -0.13 | -0.14 |
| EBITDA
| -51.618 | -91.819 | -57.602 | -43.138 | -33.228 | -28.082 | -28.218 | -30.451 | -21.269 | -14.047 | -0.827 | -0.962 |
| EBITDA Ratio
| -12.316 | -47.847 | -53.138 | -46.838 | -21.246 | -4.321 | -4.44 | -6.361 | -6.002 | -4.429 | -0.234 | -0.349 |